Survey of Ophthalmology
Volume 47, Issue 5 , Pages 397-430 , September 2002

Non-Cancerous Ophthalmic Clues to Non-Ocular Cancer

  • Dennis M Robertson, MD

      Affiliations

    • Corresponding Author InformationReprint address: Dennis M. Robertson, MD, Department of Ophthalmology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905 USA

References 

  1. Adamus G. Antirecoverin antibodies and autoimmune retinopathy. Arch Ophthalmol. 2000;118:1577–1578
  2. Adamus G, Amundson D, MacKay C, Gouras P. Long-term persistence of antirecoverin antibodies in endometrial cancer- associated retinopathy. Arch Ophthalmol. 1998;116:251–253
  3. Adamus G, Amundson D, Seigel GM, Machnicki M. Anti-enolase-alpha autoantibodies in cancer-associated retinopathy (epitope mapping and cytotoxicity on retinal cells). J Autoimmun. 1998;11:671–677
  4. Adamus G, Aptsiauri N, Guy J, et al.  The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin Immunol Immunopathol. 1996;78:120–129
  5. Adamus G, Aptsiauri N, Guy J, et al.  The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin Immunol Immunopathol. 1996;78:120–129
  6. Albu E, Reed M, Pathak R, et al.  Malignancy in HIV/AIDs (a single hospital experience). J Surg Oncol. 2000;75:11–18
  7. Ando E, Ando Y, Maruoka S, et al.  Ocular microangiopathy in familial amyloidotic polyneuropathy, type I. Graefes Arch Clin Exp Ophthalmol. 1992;230:1–5
  8. Annesley WH, Leonard BC, Shields JA, Tasman WS. Fifteen-year review of treated cases of retinal angiomatosis. Trans Am Acad Ophthalmol Otolaryngol. 1977;83:446–453
  9. Arnold RW, Stickler GB, Bourne WM, Mellinger JF. Corneal crystals, myopathy and nephropathy (a new syndrome?). J Pediatr Ophthalmol Strabismus. 1987;24:151–155
  10. Barbazetto IA, Schmidt-Erfurth UM: Photodynamic therapy (PDT) in the treatment of intraocular angioma. Scientific Poster. 103rd Annual Meeting of the American Academy of Ophthalmology, Orlando, FL, Oct 24–27, 1999
  11. Barr CC, Gelender H, Font RL. Corneal crystalline deposits associated with dysproteinemia. Report of two cases and review of the literature. Arch Ophthalmol. 1980;98:884–889
  12. Barr CC, Zimmerman LE, Curtin VT, Font RL. Bilateral diffuse melanocytic uveal tumors associated with systemic malignant neoplasms. A recently recognized syndrome. Arch Ophthalmol. 1982;100:249–255
  13. Berger JR, Mehari E. Paraneoplastic opsoclonus-myoclonus secondary to malignant melanoma. J Neurooncol. 1999;41:43–45
  14. Blair NP, Trempe CL. Hypertrophy of the retinal pigment epithelium associated with Gardners syndrome. Am J Ophthalmol. 1980;90:661–667
  15. Boeck K, Hofmann S, Klopfer M, et al.  Melanoma-associated paraneoplastic retinopathy (case report and review of the literature). Br J Dermatol. 1997;137:457–460
  16. Borkowski LM, Grover S, Fishman GA, Jampol LM. Retinal findings in melanoma-associated retinopathy. Am J Ophthalmol. 2001;132:273–275
  17. Borruat FX, Othenin-Girard P, Uffer S, et al.  Natural history of diffuse uveal melanocytic proliferation. Case report. Ophthalmology. 1992;99:1698–1704
  18. Bourne WM, Kyle RA, Brubaker RF, Greipp PR. Incidence of corneal crystals in the monoclonal gammopathies. Am J Ophthalmol. 1989;107:192–193
  19. Bouzas EA, Parry DM, Eldridge R, Kaiser-Kupfer MI. Familial occurrence of combined pigment epithelial and retinal hamartomas associated with neurofibromatosis 2. Retina. 1992;12:103–107
  20. Breslow NE, Takashima JR, Ritchey ML, et al.  Renal failure in the Denys-Drash and Wilms tumor-aniridia syndromes. Cancer Res. 2000;60:4030–4032
  21. Brink H, Deutman A, Beex L. Unusual retinal pigment epitheliopathy and choroidopathy in carcinomatosis (a rare case of cancer-associated retinopathy). Graefes Arch Clin Exp Ophthalmol. 1997;235:59–61
  22. Brown GC, Brown MM, Hiller T, et al.  Cotton-wool spots. Retina. 1985;5:206–214
  23. Brubaker RF, Wong VG, Schulman JD, et al.  Benign cystinosis. The clinical, biochemical and morphologic findings in a family with two affected siblings. Am J Med. 1970;49:546–550
  24. Buchanan TA, Gardiner TA, Archer DB. An ultrastructural study of retinal photoreceptor degeneration associated with bronchial carcinoma. Am J Ophthalmol. 1984;97:277–287
  25. Buettner H. Congenital hypertrophy of the retinal pigment epithelium. Am J Ophthalmol. 1975;79:177–189
  26. Campo E, Brunier MN, Merino MJ. Small cell carcinoma of the endometrium with associated ocular paraneoplastic syndrome. Cancer. 1992;69:2283–2288
  27. Carney JA. Carney complex (the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas). Semin Dermatol. 1995;14:90–98
  28. Cetta F, Montalto G, Gori M, et al.  Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma (results from a European cooperative study). J Clin Endocrinol Metab. 2000;85:286–292
  29. Chan CC, Vortmeyer AO, Chew EY, et al.  VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma. Arch Ophthalmol. 1999;117:625–630
  30. Char DH, Ljung BM, Miller T, Phillips T. Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology. 1988;95:625–630
  31. Charpentier P, Bloch-Michel E, Caillou B, et al: [A case of Torres syndrome: association of a meibomian adenocarcinoma with a cecal tumor]. J Fr Ophtalmol 8:479–85, 1985
  32. Cher L, Glass J, Harsh GR, Hochberg FH. Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy (preliminary results). Neurology. 1996;46:1757–1759
  33. Churchill AJ, Hanson IM, Markham AF. Prenatal diagnosis of aniridia. Ophthalmology. 2000;107:1153–1156
  34. Cina SJ, Radentz SS, Smialek JE. A case of familial angiolipomatosis with Lisch nodules. Arch Pathol Lab Med. 1999;123:946–948
  35. Cornblath WT, Dotan SA, Trobe JD, Headington JT. Varied clinical spectrum of necrobiotic xanthogranuloma. Ophthalmology. 1992;99:103–107
  36. Courcoutsakis NA, Chow CK, Shawker TH, et al.  Syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex) (breast imaging findings). Radiology. 1997;205:221–227
  37. Crofts JW, Bachynski BN, Odel JG. Visual paraneoplastic syndrome associated with undifferentiated endometrial carcinoma. Can J Ophthalmol. 1988;23:128–132
  38. de Jong PT, Verkaart RJ, van de Vooren MJ, et al.  Twin vessels in von Hippel-Lindau disease. Am J Ophthalmol. 1988;105:165–169
  39. DeBella K, Szudek J, Friedman JM. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000;105:608–614
  40. Dennehy PJ, Feldman GL, Kambouris M, et al.  Relationship of familial prominent corneal nerves and lesions of the tongue resembling neuromas to multiple endocrine neoplasia type 2B. Am J Ophthalmol. 1995;120:456–461
  41. Dhaliwal RS, Schachat AP. Remote effects of cancer on the retina. In:  Ryan SJ editors. Retina. St. Louis, MO: Mosby Inc; 2001;p. 617–624 ed 3,
  42. Dhaliwal RS, Schachat AP. Leukemias and lymphomas. In:  Ryan SJ editors. Retina. St. Louis, MO: Mosby Inc; 2001;p. 850–853 ed 3,
  43. Diaz Llopis M, Menezo JL. Congenital hypertrophy of the retinal pigment epithelium and familial polyposis of the colon. Am J Ophthalmol. 1987;103:235–236
  44. Digre KB. Opsoclonus in adults. Report of three cases and review of the literature. Arch Neurol. 1986;43:1165–1175
  45. Dua HS, Azuara-Blanco A. Allo-limbal transplantation in patients with limbal stem cell deficiency. Br J Ophthalmol. 1999;83:414–419
  46. Dubrey SW, Cha K, Anderson J, et al.  The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. Q J Med. 1998;91:141–157
  47. Eltabbakh GH, Hoogerland DL, Kay MC. Paraneoplastic retinopathy associated with uterine sarcoma. Gynecol Oncol. 1995;58:120–123
  48. Eng C, Clayton D, Schuffenecker I, et al.  The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA. 1996;276:1575–1579
  49. Feldkamp MM, Gutmann DH, Guha A. Neurofibromatosis type 1 (piecing the puzzle together). Can J Neurol Sci. 1998;25:181–191
  50. Ferry AP. Other phakomatosis. In:  Ryan SJ editors. Retina. St. Louis, MO: Mosby Inc; 2001;p. 603–607 ed 3,
  51. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med. 1993;119:1093–1104
  52. Fishburne BC, Wilson DJ, Rosenbaum JT, Neuwelt EA. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol. 1997;115:1152–1156
  53. Freeman WR, Chen A, Henderly DE, et al: Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy. Am J Ophthalmol 107:229Mosby Inc35, 1989
  54. Gass JD, Gieser RG, Wilkinson CP, et al.  Bilateral diffuse uveal melanocytic proliferation in patients with occult carcinoma. Arch Ophthalmol. 1990;108:527–533
  55. Gass JD, Weleber RG, Johnson DR. Non-Hodgkins lymphoma causing fundus picture simulating fundus flavimaculatus. Retina. 1987;7:209–214
  56. Gass JDM. Acute Vogt-Koyanagi-Harada-like syndrome occurring in a patient with metastatic cutaneous melanoma. In:  Saari KH editors. Uveitis update (proceedings of the international symposium on uveitis). Amsterdam: Elsevier; 1984;
  57. Gehrs K, Tiedeman J. Hemeralopia in an older adult. Surv Ophthalmol. 1992;37:185–189
  58. Gertz MA, Kyle RA. Amyloidosis. In:  Wiernik PH,  Canellos GP,  Dutcher JP editor. Neoplastic Diseases of the Blood. New York: Churchill Livingstone; 1996;p. 635–677 ed 3,
  59. Gertz MA, Kyle RA, Thibodeau SN. Familial amyloidosis (a study of 52 North American-born patients examined during a 30-year period). Mayo Clin Proc. 1992;67:428–440
  60. Gittinger JW, Smith TW. Cutaneous melanoma-associated paraneoplastic retinopathy (histopathologic observations). Am J Ophthalmol. 1999;127:612–614
  61. Goldstein SM, Syed NA, Milam AH, et al.  Cancer-associated retinopathy. Arch Ophthalmol. 1999;117:1641–1645
  62. Greenwald MJ, Weiss A. Ocular manifestations of the neurocutaneous syndromes. Pediatr Dermatol. 1984;2:98–117
  63. Grunwald GB, Klein R, Simmonds MA, Kornguth SE. Autoimmune basis for visual paraneoplastic syndrome in patients with small-cell lung carcinoma. Lancet. 1985;1:658–661
  64. Grunwald GB, Kornguth SE, Towfighi J, et al.  Autoimmune basis for visual paraneoplastic syndrome in patients with small cell lung carcinoma. Retinal immune deposits and ablation of retinal ganglion cells. Cancer. 1987;60:780–786
  65. Gupta SK, De Becker I, Guernsey DL, Neumann PE. Polymerase chain reaction-based risk assessment for Wilms tumor in sporadic aniridia. Am J Ophthalmol. 1998;125:687–692
  66. Gutman DH, Aylsworth A, Carey JC, et al.  The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1999;278:51–57
  67. Guy J, Aptsiauri N. Treatment of paraneoplastic visual loss with intravenous immunoglobulin (report of 3 cases). Arch Ophthalmol. 1999;117:471–477
  68. Haase GM, Perez C, Atkinson JB. Current aspects of biology, risk assessment, and treatment of neuroblastoma. Semin Surg Oncol. 1999;16:91–104
  69. Hardwig P, Robertson DM. von Hippel-Lindau disease (a familial, often lethal, multi-system phakomatosis). Ophthalmology. 1984;91:263–270
  70. Harmon JP, Purvin VA, Guy J, et al.  Cancer-associated retinopathy in a patient with advanced epithelial ovarian carcinoma. Gynecol Oncol. 1999;73:430–432
  71. Harnois C, Boisjoly HM, Jotterand V. Sporadic aniridia and Wilms tumor (visual function evaluation of three cases). Graefes Arch Clin Exp Ophthalmol. 1989;227:244–247
  72. Hartmann RW, Tunnessen WW. Picture of the month. Congenital aniridia. Arch Pediatr Adolesc Med. 2000;154:525–526
  73. Hawkins AS, Stein RM, Gaines BI, Deutsch TA. Ocular deposition of copper associated with multiple myeloma. Am J Ophthalmol. 2001;131:257–259
  74. Heckenlively JR, Fawzi AA, Oversier J, et al.  Autoimmune retinopathy. Patients with anti-recoverin immunoreactivity and panretinal degeneration. Arch Ophthalmol. 2000;118:1523–1533
  75. Hersh B, Dalmau J, Dangond F, et al.  Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody. Neurology. 1994;44:1754–1755
  76. Hoff AO, Cote GJ, Gagel RF. Multiple endocrine neoplasias. Annu Rev Physiol. 2000;62:377–411
  77. In:  Hogan MJ,  Zimmerman LE editor. Ophthalmic Pathology, an Atlas and Textbook. Philadelphia: WB Saunders; 1962; ed 2, p365
  78. Holland GN, Gottlieb MS, Yee RD, et al.  Ocular disorders associated with a new severe acquired cellular immunodeficiency syndrome. Am J Ophthalmol. 1982;93:393–402
  79. Holland GN, Pepose JS, Pettit TH, et al.  Acquired immune deficiency syndrome. Ocular manifestations. Ophthalmology. 1983;90:859–873
  80. Humphrey JS, Klausner RD, Linehan WM: von Hippel-Lindau syndrome: hereditary cancer arising from inherited mutations of the VHL tumor suppressor gene, in Pienta KJ: Diagnosis and Treatment of Genitourinary Malignancies. Boston, MA, Kluwer Academic Publishers 1996, pp 13–39
  81. Hutchinson K, Dal Pra M, Apel A. Immunoglobulin G crystalline keratopathy associated with monoclonal gammopathy. Aust NZ J Ophthalmol. 1998;26:177–179
  82. Imes RK, Monteiro MLR, Hoyt WF. Incipient hemangioblastoma of the optic disk. Am J Ophthalmol. 1984;98:116
  83. Ing EB, Younge BR, Leavitt JA, et al.  Paraneoplastic retinopathy and gynecologic malignancy. J Pelvic Surg. 1995;1:79–83
  84. Jabs DA. Acquired immunodeficiency syndrome and the eye—1996. Arch Ophthalmol. 1996;114:863–866
  85. Jabs DA, Bartlett JG. AIDS and ophthalmology (a period of transition). Am J Ophthalmol. 1997;124:227–233
  86. Jabs DA, Green WR, Fox R, et al.  Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology. 1989;96:1092–1099
  87. Jacobson DM. paraneoplastic diseases of neuro-ophthalmologic interest, Chapter 47. In:  Miller NR,  Newman NJ editor. Walsh and Hoyt's Clinical Neuro-Ophthalmology, Vol 2. Baltimore: Williams and Wilkins; 1998;p. 2497–2551 ed 5,
  88. Jacobson DM, Adamus G. Retinal anti-bipolar cell antibodies in a patient with paraneoplastic retinopathy and colon carcinoma. Am J Ophthalmol. 2001;131:806–808
  89. Jacobson DM, Thirkill CE. Paraneoplastic cone dysfunction (an unusual visual remote effect of cancer). Arch Ophthalmol. 1995;113:1580–1582
  90. Jakobiec FA. Sebaceous adenoma of the eyelid and visceral malignancy. Am J Ophthalmol. 1974;78:952–960
  91. Jakobiec FA, Font RL, Johnson FB. Angiomatosis retinae. An ultrastructural study and lipid analysis. Cancer. 1976;38:2042–2056
  92. Jampol LM, Sieving PA, Pugh D, et al.  Multiple evanescent white dot syndrome. I. Clinical findings. Arch Ophthalmol. 1984;102:671–674
  93. Jampol LM, Tsai L: Multiple evanescent white dot syndrome, in Ryan SJ: Retina. St. Louis, MO, Mosby Inc, 2001, ed 3, pp 1721–6
  94. Kane LA, Tsai MS, Gharib H, et al.  Familial medullary thyroid cancer and prominent corneal nerves (clinical and genetic analysis). J Clin Endocrinol Metab. 1995;80:289–293
  95. Kanoh T, Ikeda M, Takamatsu T, et al: [Periorbital ecchymoses without evidence of amyloid deposition as the initial sign in multiple myeloma]. Nippon Naika Gakkai Zasshi 76:1740–1, 1987
  96. Kasner L, Traboulsi EI, Delacruz Z, Green WR. A histopathologic study of the pigmented fundus lesions in familial adenomatous polyposis. Retina. 1992;12:34–42
  97. Kass LG, Hornblass A. Sebaceous carcinoma of the ocular adnexa. Surv Ophthalmol. 1989;33:477–490
  98. Kellner U, Bornfeld N, Foerster MH. Severe course of cutaneous melanoma associated paraneoplastic retinopathy. Br J Ophthalmol. 1995;79:746–752
  99. Keltner JL, Roth AM, Chang RS. Photoreceptor degeneration. Possible autoimmune disorder. Arch Ophthalmol. 1983;101:564–569
  100. Keltner JL, Thirkill CE, Tyler NK, Roth AM. Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol. 1992;110:48–53
  101. Kennedy RH, Flanagan JC, Eagle RC, Carney JA. The Carney complex with ocular signs suggestive of cardiac myxoma. Am J Ophthalmol. 1991;111:699–702
  102. Kennedy RH, Waller RR, Carney JA. Ocular pigmented spots and eyelid myxomas. Am J Ophthalmol. 1987;104:533–538
  103. Kestelyn P, Stevens AM, Bakkers E, et al.  Severe herpes zoster ophthalmicus in young African adults (a marker for HTLV-III seropositivity). Br J Ophthalmol. 1987;71:806–809
  104. Kikuchi T, Arai J, Shibuki H, et al.  Tubby-like protein 1 as an autoantigen in cancer-associated retinopathy. J Neuroimmunol. 2000;103:26–33
  105. Kim RY, Retsas S, Fitzke FW, et al.  Cutaneous melanoma-associated retinopathy. Ophthalmology. 1994;101:1837–1843
  106. Kirschner LS, Carney JA, Pack SD, et al.  Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet. 2000;26:89–92
  107. Klingele TG, Burde RM, Rappazzo JA, et al.  Paraneoplastic retinopathy. J Clin Neuroophthalmol. 1984;4:239–245
  108. Klintworth GK, Bredehoeft SJ, Reed JW. Analysis of corneal crystalline deposits in multiple myeloma. Am J Ophthalmol. 1978;86:303–313
  109. Kollarits CR, Mehelas TJ, Shealy TR, Zahn JR. von Hippel tumors in siblings with retinitis pigmentosa. Ann Ophthalmol. 1982;14:256–259
  110. Kornguth SE, Klein R, Appen R, Choate J. Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Cancer. 1982;50:1289–1293
  111. Kossard S, Winkelmann RK. Necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol. 1980;3:257–270
  112. Kreusel KM, Bechrakis NE, Heinichen T, et al.  Retinal angiomatosis and von Hippel-Lindau disease. Graefes Arch Clin Exp Ophthalmol. 2000;238:916–921
  113. Kurumety UR, Lustbader JM. Kaposis sarcoma of the bulbar conjunctiva as an initial clinical manifestation of acquired immunodeficiency syndrome. Arch Ophthalmol. 1995;113:978
  114. Kyle RA, Gertz MA. Primary systemic amyloidosis (clinical and laboratory features in 474 cases). Semin Hematol. 1995;32:45–59
  115. Kyle RA, Greipp PR. Amyloidosis (AL). Clinical and laboratory features in. 1983;229(cases. Mayo Clin Proc 58):665–683
  116. Lam DS, Kwok SP, Kwok AK, et al.  Incidence and predictive value of congenital hypertrophy of retinal pigment epithelium in Chinese familial adenomatous polyposis patients. Chin Med J (Engl). 1998;111:278–281
  117. Lang GK, Surer JL, Green WR, et al.  Ocular reticulum cell sarcoma. Clinicopathologic correlation of a case with multifocal lesions. Retina. 1985;5:79–86
  118. Laycock KA, Pepose JS. HIV infection and AIDS (Background and recent developments). In:  Stenson SM,  Friedberg DN editor. AIDS and the eye. New Orleans, LA: Contact Lens Association of Ophthalmologists, Inc; 1995;
  119. Leahey AB, Shane JJ, Listhaus A, Trachtman M. Molluscum contagiosum eyelid lesions as the initial manifestation of acquired immunodeficiency syndrome. Am J Ophthalmol. 1997;124:240–241
  120. Lewis H, Schachat AP. Non-Hodgkin's (“reticulum cell”) lymphoma. In:  Ryan SJ editors. Retina. St. Louis, MO: Mosby Inc; 2001;p. 859–868 ed 3,
  121. Lewis RA, Crowder WE, Eierman LA, et al.  The Gardner syndrome. Significance of ocular features. Ophthalmology. 1984;91:916–925
  122. Lewis RA, Falls HF, Troyer DO. Ocular manifestations of hypercupremia associated with multiple myeloma. Arch Ophthalmol. 1975;93:1050–1053
  123. Lewis RA, Riccardi VM. Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata. Ophthalmology. 1981;88:348–354
  124. Liesegang TJ. Varicella-zoster virus eye disease. Cornea. 1999;18:511–531
  125. Lightman S, Marsh RJ, Powell D. Herpes zoster ophthalmicus (a medical review). Br J Ophthalmol. 1981;65:539–541
  126. Loo H, Forman WB, Levine MR, et al: Periorbital ecchymoses as the initial sign in multiple myeloma. Ann Ophthalmol:1066–8, 1992
  127. Luque FA, Furneaux HM, Ferziger R, et al.  Anti-Ri (an antibody associated with paraneoplastic opsoclonus and breast cancer). Ann Neurol. 1991;29:241–251
  128. Macher AM, Palestine A, Masur H, et al.  Multicentric Kaposis sarcoma of the conjunctiva in a male homosexual with the acquired immunodeficiency syndrome. Ophthalmology. 1983;90:879–884
  129. Maher ER, Yates JR, Harries R, et al.  Clinical features and natural history of von Hippel-Lindau disease. Q J Med. 1990;77:1151–1163
  130. Malik S, Furlan AJ, Sweeney PJ, et al.  Optic neuropathy (a rare paraneoplastic syndrome). J Clin Neuroophthalmol. 1992;12:137–141
  131. Margo CE, Pavan PR, Gendelman D, Gragoudas E. Bilateral melanocytic uveal tumors associated with systemic non-ocular malignancy. Malignant melanomas or benign paraneoplastic syndrome?. Retina. 1987;7:137–141
  132. Marsh RJ. Editorial (Herpes zoster ophthalmicus and AIDS). Br J Ophthalmol. 1987;71:805
  133. Martin NF, Kincaid MC, Stark WJ, et al.  Ocular copper deposition associated with pulmonary carcinoma, IgG monoclonal gammopathy and hypercupremia. A clinicopathologic correlation. Ophthalmology. 1983;90:110–116
  134. Matsui Y, Mehta MC, Katsumi O, et al.  Electrophysiological findings in paraneoplastic retinopathy. Graefes Arch Clin Exp Ophthalmol. 1992;230:324–328
  135. McGaughran JM, Harris DI, Donnai D, et al.  A clinical study of type 1 neurofibromatosis in north west England. J Med Genet. 1999;36:197–203
  136. Meier-Gibbons F, Messmer E. Sebaceous gland adenoma of the palpebral conjunctiva in a patient with Muir-Torre-syndrome (a case report). Graefes Arch Clin Exp Ophthalmol. 1994;232:734–736
  137. Michels VV. Von Hippel-Lindau disease. In:  Rosenberg RN,  Prusener SB,  DiMauros Barchi RL,  Kunkel LM editor. The molecular and genetic basis of neurologic disease. Boston, MA: Butterworth-Heinemann; 1993;p. 807–813
  138. Milam AH, Saari JC, Jacobson SG, et al.  Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci. 1993;34:91–100
  139. Mizener JB, Kimura AE, Adamus G, et al.  Autoimmune retinopathy in the absence of cancer. Am J Ophthalmol. 1997;123:607–618
  140. Mooy CM, de Jong PT, Strous C. Proliferative activity in bilateral paraneoplastic melanocytic proliferation and bilateral uveal melanoma. Br J Ophthalmol. 1994;78:483–484
  141. Munden PM, Sobol WM, Weingeist TA. Ocular findings in Turcot syndrome (glioma-polyposis). Ophthalmology. 1991;98:111–114
  142. Murray K, Kun L, Cox J. Primary malignant lymphoma of the central nervous system. Results of treatment of. 1986;11(cases and review of the literature. J Neurosurg 65):600–607
  143. Neault RW, Van Scoy RE, Okazaki H, MacCarty CS. Uveitis associated with isolated reticulum cell sarcoma of the brain. Am J Ophthalmol. 1972;73:431–436
  144. Nicholson D. Capillary hemangioma of the retina and von Hippel-Lindau disease. In:  Ryan SJ editors. Retina. St. Louis, MO: Mosby; 2001;p. 633–640 ed 3,
  145. Nitschke J, Hochberg F. Improvement of paraneoplastic opsoclonus-myoclonus after Protein A column therapy. N Engl J Med. 1995;332:192; [letter]
  146. Ohguro H, Ogawa K, Maeda T, et al.  Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo. Invest Ophthalmol Vis Sci. 1999;40:3160–3167
  147. Ohkawa T, Kawashima H, Makino S, et al.  Cancer-associated retinopathy in a patient with endometrial cancer. Am J Ophthalmol. 1996;122:740–742
  148. Ohnishi Y, Ohara S, Sakamoto T, et al.  Cancer-associated retinopathy with retinal phlebitis. Br J Ophthalmol. 1993;77:795–798
  149. Palestine AG, Rodrigues MM, Macher AM, et al.  Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology. 1984;91:1092–1099
  150. Pang CP, Keung JW, Tang NL, et al.  Congenital hypertrophy of the retinal pigment epithelium and APC mutations in two Chinese families with familial adenomatous polyposis. Eye. 2000;14:18–22
  151. Patel RJ, Appukuttan B, Ott S, et al.  DNA-based diagnosis of the von Hippel-Lindau syndrome. Am J Ophthalmol. 2000;129:258–260
  152. Peek R, Verbraak F, Coevoet HM, Kijlstra A. Muller cell-specific autoantibodies in a patient with progressive loss of vision. Invest Ophthalmol Vis Sci. 1998;39:1976–1979
  153. Pepkowitz S, Reader A, Jacobs A, et al.  Paraneoplastic retinopathy (resolution with plasmapheresis). Transfusion. 1993;33:71S; [abstract]
  154. Pinkerton RM, Robertson DM. Corneal and conjunctival changes in dysproteinemia. Invest Ophthalmol. 1969;8:357–364
  155. Polans AS, Buczylko J, Crabb J, Palczewski K. A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J Cell Biol. 1991;112:981–989
  156. Polans AS, Burton MD, Halet TL, et al.  Recoverin, but not visinin, is an autoantigen in the human retina identified with a cancer-associated retinopathy. Invest Ophthalmol Vis Sci. 1993;34:89–90
  157. Polans AS, Witkowska D, Haley TL, et al.  Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci USA. 1995;92:9176–9180
  158. Potter MJ, Thirkill CE, Dam OM, et al.  Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy. Ophthalmology. 1999;106:2121–2125
  159. Powell SM, Petersen GM, Krush AJ, et al.  Molecular diagnosis of familial adenomatous polyposis. N Engl J Med. 1993;329:1982–1987
  160. Pranzatelli MR, Huang YY, Tate E, et al.  Monoaminergic effects of high-dose corticotropin in corticotropin-responsive pediatric opsoclonus-myoclonus. Mov Disord. 1998;13:522–528
  161. Raber W, Raffesberg W, Bischof M, et al.  Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma. Arch Intern Med. 2000;160:2957–2963
  162. Remulla JF, Pineda R, Gaudio AR, Milam AH. Cutaneous melanoma-associated retinopathy with retinal periphlebitis. Arch Ophthalmol. 1995;113:854–855
  163. Reni M, Ferreri AJ, Garancini MP, Villa E. Therapeutic management of primary central nervous system lymphoma in immunocompetent patients (results of a critical review of the literature). Ann Oncol. 1997;8:227–234
  164. Ridley ME, McDonald HR, Sternberg P, et al.  Retinal manifestations of ocular lymphoma (reticulum cell sarcoma). Ophthalmology. 1992;99:1153–1160 discussion 1160–1
  165. Riley FC, Robertson DM. Ocular histopathology in multiple endocrine neoplasia type 2b. Am J Ophthalmol. 1981;91:57–64
  166. Rizzo JF, Gittinger JW. Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome. Ophthalmology. 1992;99:1286–1295
  167. Robertson DM, Campbell RJ. Intravitreal invasion of malignant cells from choroidal melanoma after brachytherapy. Arch Ophthalmol. 1997;115:793–795
  168. Robertson DM, Sizemore GW, Gordon H. Thickened corneal nerves as a manifestation of multiple endocrine neoplasia. Trans Am Acad Ophthalmol Otolaryngol. 1975;79:772–787
  169. Robertson DM, Winkelmann RK. Ophthalmic features of necrobiotic xanthogranuloma with paraproteinemia. Am J Ophthalmol. 1984;97:173–183
  170. Rosa RH, Goldberg MF, Green WR. Clinicopathologic correlation of argon laser photocoagulation of retinal angiomas in a patient with von Hippel-Lindau disease followed for more than 20 years. Retina. 1996;16:145–156
  171. Rosenberg PR, Uliss AE, Friedland GH, et al.  Acquired immunodeficiency syndrome. Ophthalmic manifestations in ambulatory patients. Ophthalmology. 1983;90:874–878
  172. Ruhswurm I, Zehetmayer M, Dejaco C, et al.  Ophthalmic and genetic screening in pedigrees with familial adenomatous polyposis. Am J Ophthalmol. 1998;125:680–686
  173. Russo C, Cohn SL, Petruzzi MJ, de Alarcon PA. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma (a report from the Pediatric Oncology Group). Med Pediatr Oncol. 1997;28:284–288
  174. Ryll DL, Campbell RJ, Robertson DM, Brubaker SJ. Pseudometastatic lesions of the choroid. Ophthalmology. 1980;87:1181–1186
  175. Sandor EV, Millman A, Croxson TS, Mildvan D. Herpes zoster ophthalmicus in patients at risk for the acquired immune deficiency syndrome (AIDS). Am J Ophthalmol. 1986;101:153–155
  176. Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol. 1976;81:606–613
  177. Scaravilli F, An SF, Groves M, Thom M. The neuropathology of paraneoplastic syndromes. Brain Pathol. 1999;9:251–260
  178. Schmidt D, Jung CE, Wolff G. Changes in the retinal pigment epithelium close to retinal vessels in familial adenomatous polyposis. Graefes Arch Clin Exp Ophthalmol. 1994;232:96–102
  179. Scholl HP, Zrenner E. Electrophysiology in the investigation of acquired retinal disorders. Surv Ophthalmol. 2000;45:29–47
  180. Schonherr U: [Acute reversible night blindness caused by vitamin A deficiency in pancreatic carcinoma]. Klin Monatsbl Augenheilkd 213:108–11, 1998
  181. Singh AD, Milam AH, Shields CL, et al.  Melanoma-associated retinopathy. Am J Ophthalmol. 1995;119:369–370
  182. Smith ME, Zimmerman LE. Amyloidosis of the eyelid and conjunctiva. Arch Ophthalmol. 1966;75:42–51
  183. Stenson SM, Friedberg: AIDS and the Eye. New Orleans LA, Contact Lens Association of Ophthalmologists, Inc., 1995, p 154
  184. Stolle C, Glenn G, Zbar B, et al.  Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat. 1998;12:417–423
  185. Stratakis CA. Genetics of Carney complex and related familial lentiginoses, and other multiple tumor syndromes. Front Biosci. 2000;5:D353–D366
  186. Stratakis CA, Ball DW. A concise genetic and clinical guide to multiple endocrine neoplasias and related syndromes. J Pediatr Endocrinol Metab. 2000;13:457–465
  187. Stratakis CA, Kirschner LS, Taymans SE, et al.  Carney complex, Peutz-Jeghers syndrome, Cowden disease, and Bannayan-Zonana syndrome share cutaneous and endocrine manifestations, but not genetic loci. J Clin Endocrinol Metab. 1998;83:2972–2976
  188. Suzuki T, Obara Y, Sato Y, et al.  Cancer-associated retinopathy with presumed vasculitis. Am J Ophthalmol. 1996;122:125–127
  189. Tabarki B, Palmer P, Lebon P, Sebire G. Spontaneous recovery of opsoclonus-myoclonus syndrome caused by enterovirus infection. J Neurol Neurosurg Psychiatry. 1998;64:406–407
  190. Thirkill CE, FitzGerald P, Sergott RC, et al.  Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. N Engl J Med. 1989;321:1589–1594
  191. Thirkill CE, Keltner JL, Tyler NK, Roth AM. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy. Arch Ophthalmol. 1993;111:931–937
  192. Thirkill CE, Roth AM, Keltner JL. Cancer-associated retinopathy. Arch Ophthalmol. 1987;105:372–375
  193. Thirkill CE, Tait RC, Tyler NK, et al.  The cancer-associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci. 1992;33:2768–2772
  194. Thomas HI, Aird HC. Maintenance of high-avidity rubella-specific IgG antibody and titres in recent HIV seroconvertors and in patients progressing to the AIDS-related complex and AIDS. J Med Virol. 1999;58:273–279
  195. Tonelli F, Valanzano R, Messerini L, Ficari F. Long-term treatment with sulindac in familial adenomatous polyposis (is there an actual efficacy in prevention of rectal cancer?). J Surg Oncol. 2000;74:15–20
  196. Traboulsi EI, Krush AJ, Gardner EJ, et al.  Prevalence and importance of pigmented ocular fundus lesions in Gardners syndrome. N Engl J Med. 1987;316:661–667
  197. Traboulsi EI, Maumenee IH, Krush AJ, et al.  Pigmented ocular fundus lesions in the inherited gastrointestinal polyposis syndromes and in hereditary nonpolyposis colorectal cancer. Ophthalmology. 1988;95:964–969
  198. Ugurlu S, Bartley GB, Gibson LE. Necrobiotic xanthogranuloma (long-term outcome of ocular and systemic involvement). Am J Ophthalmol. 2000;129:651–657
  199. Umbert I, Winkelmann RK. Necrobiotic xanthogranuloma with cardiac involvement. Br J Dermatol. 1995;133:438–443
  200. Vaidya SM, Kamalakar PL. Copper and ceruloplasmin levels in serum of women with breast cancer. Indian J Med Sci. 1998;52:184–187
  201. Valluri S, Moorthy RS, Khan A, Rao NA. Combination treatment of intraocular lymphoma. Retina. 1995;15:125–129
  202. Vaphiades MS, Brown H, Whitcup SM. Node way out. Surv Ophthalmol. 2000;45:77–83
  203. Veneselli E, Conte M, Biancheri R, et al.  Effect of steroid and high-dose immunoglobulin therapy on opsoclonus-myoclonus syndrome occurring in neuroblastoma. Med Pediatr Oncol. 1998;30:15–17
  204. Webster AR, Maher ER, Moore AT. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch Ophthalmol. 1999;117:371–378
  205. Weinstein JM, Kelman SE, Bresnick GH, Kornguth SE. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma. Ophthalmology. 1994;101:1236–1243
  206. Wheeland RG, Thurmond RD, Gilmore WA, Blackstock R. Chronic blepharitis and pyoderma of the scalp (an immune deficiency state in a father and son with hypercupremia and decreased intracellular killing). Pediatr Dermatol. 1983;1:134–142
  207. Whitcup SM, Vistica BP, Milam AH, et al.  Recoverin-associated retinopathy (a clinically and immunologically distinctive disease). Am J Ophthalmol. 1998;126:230–237
  208. Wolf MT, Lorenz B, Winterpacht A, et al.  Ten novel mutations found in Aniridia. Hum Mutat. 1998;12:304–313
  209. Womack LW, Liesegang TJ. Complications of herpes zoster ophthalmicus. Arch Ophthalmol. 1983;101:42–45
  210. Yanoff M, Sharaby ML. Multiple endocrine neoplasia type IIB. Arch Ophthalmol. 1996;114:228–229
  211. Yoon YH, Cho EH, Sohn J, Thirkill CE. An unusual type of cancer-associated retinopathy in a patient with ovarian cancer. Korean J Ophthalmol. 1999;13:43–48

PII: S0039-6257(02)00332-6

Survey of Ophthalmology
Volume 47, Issue 5 , Pages 397-430 , September 2002

Article Tools

* Image Usage & Resolution